Emergent BioSolutions Inc. EBS
6.61 USD -0.20 -2.90%
As of Nov 2, 1:51 PM ET
- YTD
- -46.50%
- 1 year
- -47.01%
- Open
- 6.82
- Prev close
- 6.81
- Mkt cap
- 339.43M
- Vol
- 236.23K
- Avg vol
- 1.23M
- EPS
- -3.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.60
- High
- 6.88
- Forward P/E
- 2.73
- Beta
- 1.57
- Short ratio
- 4.54
- Inst. own
- 60.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.27
- 200-d avg
- 7.13
- 1y target
- 12.00
5D chart
Chart tools
Chart is warming up
The five-day price history for EBS has not been loaded yet. Try again in a moment.
Altman Z-Score
0.84 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
P/E 12.6×
P/S 0.9×
P/B 1.3×
P/FCF 4.2×
EV/EBITDA 4.3×
EV/Sales 1.4×
FCF Yield 23.7%
Gross Margin 47.2%
Operating Margin 14.8%
Net Margin 7.1%
ROE 10.1%
ROIC 5.9%
ROA 4.0%
Revenue -28.8%
Operating Income 201.4%
EPS (diluted) 125.8%
Free Cash Flow 338.0%
Current Ratio 5.0×
Quick Ratio 2.4×
Debt / Equity 1.1×
Net Debt / EBITDA 1.5×
Interest Coverage 1.9×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31